Author: James Noyes

  • McGovern leads bipartisan effort to support, expand ‘food is medicine’ initiatives

    Repeating the mantra that “food is medicine,” U.S. Rep. Jim McGovern is leading a bipartisan effort urging congressional appropriators to make healthy food and good nutrition a core pillar of the nation’s health care system.

    “I believe that food is a human right. And I also believe that the United States has kind of lagged behind other countries in terms of making the connection between good nutrition and better health outcomes,” said McGovern in an interview with the Gazette.

    He continued, “Bad diets result in heart disease, bad diets can result in diabetes, bad diets can result in high blood pressure and I can go right down the list. We have senior citizens who are in the emergency room because they’re taking their medication on an empty stomach, because they can’t afford their medicine and their food.”

    That’s why McGovern recently drafted a letter, signed by 46 House members from both sides of the aisle, asking appropriators to “provide essential resources and timely guidance to better integrate nutrition into our health care system” as part of the fiscal year 2027 Labor, Health and Human Services, Education, and Related Agencies funding bill.

    “Good nutrition is fundamental for restoring and maintaining health,” the legislators wrote. “The costs of treating diet-related disease are crushing healthcare systems, federal and state budgets, private employers, and our economy… The combined healthcare spending and lost productivity from suboptimal diets and food insecurity are estimated to exceed $1.1 trillion each year.”

    The Department of Health and Human Services (HHS) developed a Food is Medicine (FiM) initiative in 2023 to create a strategy to “reduce nutrition-related chronic diseases and food insecurity to improve health in the United States,” including “diet-related research” and efforts that will increase access to Food is Medicine initiatives, according to the HHS.

    In the March 26 letter, legislators called for around $3.5 billion in additional funding to be directed to various FiM programs, including medically-tailored meals, groceries and produce prescriptions, which are customized for people with severe, complex or chronic conditions, and the Ryan White HIV/AIDS program, which provides FiM programs and HIV primary care to people living with HIV/AIDS.

    “What this letter is about is us putting some money on the table so we can move ahead on some of these initiatives,” said McGovern. “The bottom line is, we’ve got to put some money on the table here, and we have to make this a priority.”

    In addition to providing potentially life-saving nutritional supplements, expanding and supporting FiM initiatives could save the country, and individual states, money on unnecessary health care spending.

    “If we do this right, we’re going to save a boatload of money in avoidable health care costs,” McGovern said. “Health care costs are skyrocketing, and rather than going to people and telling them that ‘in order to get good health care, you got to pay more,’ how about we find ways to control costs through getting them access to better nutrition?”

    Healthy food initiatives have been one of McGovern’s primary political focuses for more than two decades; in 2001, he introduced legislation creating the George McGovern-Robert Dole International Food for Education and Child Nutrition Program, which has “provided lifesaving food” for “over 31 million of the world’s most vulnerable children in 48 different countries,” according to McGovern’s office.

    In 2008, McGovern launched the bipartisan House Hunger Caucus, and in 2018 he created the bipartisan Food is Medicine Working Group to “highlight the costs related to hunger and promote health-focused research into access to fresh fruits and vegetables.”

  • Sen. Oliveira, advocates push cancer testing bill on Beacon Hill

    Sen. Oliveira, advocates push cancer testing bill on Beacon Hill

    BOSTON — Cancer survivors convened on Beacon Hill late last month to deliver emotional testimony alongside advocates and lawmakers, urging passage of bills to expand access to biomarker testing and patient navigation services as an estimated 43,000 Massachusetts residents are expected to be diagnosed with cancer this year.

    Sen. Jacob Oliveira of Ludlow, pictured at a Joint Ways and Means Committee budget hearing in March, is the lead Senate sponsor of a biomarker testing bill as a way to test for cancer and other diseases. Credit: CHRIS LISINSKI/STATE HOUSE NEWS SERVICE

    Among them was state Sen. Jacob Oliveira, D-Ludlow, the lead Senate sponsor of the biomarker bill, which he said would be a “game-changer, not just for the health benefits of it and for the patient, but it could save our health care system, because of the fact that with biomarker testing, you could have less costly treatments that people could utilize if they can pinpoint the treatment they need.”

    After the public event on March 26, which was part of Massachusetts State Lobby Day, advocates from the American Cancer Society Cancer Action Network (ACS CAN) met individually with state legislators to encourage them to vote in favor of the bills.

    According to the ACS, biomarker testing is the analysis of a patient’s tissue, blood or other biospecimen for the presence of a biomarker, which is a unique signal in a patient’s genetics that describes “a normal biological process, disease or abnormal function.” The system, the organization says, is revolutionizing treatment for cancer and other diseases, creating more effective and precise treatment strategies faster.

    The biomarker testing bill would address health care inequities in the state by ensuring that comprehensive testing is covered by MassHealth and all state-regulated health insurance plans.

    Biomarker-informed treatment leads to higher cancer survival rates, according to the ACS: “Real-world data also show a median survival of nearly 15 months for patients who received biomarker testing compared to nine months for those who did not — a 66% increase in median survival,” the organization says.

    Overall, biomarkers “can be used to determine the best treatment for a patient” by helping to identify targeted therapies or immunotherapies most likely to be effective, while at the same time avoiding trial-and-error prescribing of treatments. ACS CAN released an explanatory video on its website to help people understand the benefits of biomarker testing.

    One of the ACS Advocates who testified at lobby day was Teresa Simpson, an actress and two-time cancer survivor from Sturbridge who is currently battling ovarian cancer. In an interview with the Gazette, Simpson said, “At 30 I had thyroid cancer, at 50 I had breast cancer, and here I was, 63, thinking ‘uh-oh, is something really wrong here?’”

    After doctors dismissed her abdominal pain as diet-related, Simpson decided to get a biomarker test. After that test, “the office calls, and says ‘oh my goodness. I guess there is something wrong. We’ll have you get a CAT scan.’ And I did, and it revealed there was cancer all over my abdomen, on my ovary, into my chest. It really looked very dire.” 

    She began chemotherapy immediately after, and has been undergoing treatment for nearly three years. Simpson decided that she wouldn’t sit idly by while undergoing chemotherapy, and began advocating on behalf of the Ovarian Cancer Research Alliance. 

    “I decided it might be a good idea to be more active,” she said. “And if I’m in between treatments, if I’m feeling well enough, I want to do something, and so I became a patient advocate for them.”

    Last fall, ACS CAN asked Simpson to speak at a rally in front of hundreds of survivors, advocates, and politicians in Washington, D.C. She has since become an outspoken advocate for ACS CAN. 

    “This is incredibly personal to me, because my particular cancer and some other cancers, their treatment really does depend on certain things they find in your tumor cells or in your blood,” said Simpson. “Because they can try the standard care, it seems to work for some and not for others. And now they can say, ‘Oh, she has this particular protein, or this particular genetic component,’ and they can target the medicine.”

    Oliveira says expanding patient access to biomarker testing could help lower the cost of health care across the state by improving individually-targeted treatment and subsequently eliminating unnecessary treatment plans. That savings could then be redirected to addressing other health care related problems, such as a primary care crisis experienced by residents of western Massachusetts. 

    “Access to a primary care doctor is very difficult… Our hospital systems are facing instability. Bay State Health is estimating a $150 million cut for themselves by the big, ugly bill that was signed into law by President Trump,” he said.

  • Can Massachusetts implement universal health care?

    An economic analysis released in February by the Massachusetts Campaign for single payer healthcare, or Mass-Care, offers some details.

    Rising health care costs and the federal government’s failure to extend Affordable Care Act subsidies has reinvigorated efforts to implement universal health care in Massachusetts.

    “The changes to the ACA on the federal level, and the increase in premiums and the end of subsidies is also creating more panic on the state level,” Rep. Lindsay Sabadosa, D-Northampton, said in an interview. She is a co-sponsor of a measure sitting in the Legislature’s Committee on Health Care Financing to establish a Medicare for All system in Massachusetts.

    “Health care costs and the provision of health care services are really at a breaking point,” Sabadosa said. “We’re hearing from doctors who can no longer afford to stay in business. We’re seeing hospitals across the state closing. We’re seeing patients waiting longer and longer and longer to see a doctor or a nurse or get treatment, and then simultaneously we’re seeing health care costs continue to go up.” 

    An economic analysis released in February by the Massachusetts Campaign for single payer healthcare, or Mass-Care, offers some details.

    “The United States as a country consistently underperforms comparable countries in both health outcomes and the cost of care,” said Auden Cote-L’Heureux, a UMass Amherst graduate now a masters student in economics at the University of Bonn in Germany. “If you look at comparable countries, we pay way more per capita for health care, and we have worse health outcomes, including lower life expectancy.” 

    At the same time, health care costs are a major concern for employers, especially small business owners.

    “We’ve consistently heard from our members, particularly our small-employer members, that health care and health insurance costs are always near the top of the list in terms of cost concerns,” said Bill Rennie, senior vice president of the Retailers Association of Massachusetts.

    Rennie said that members of the association, which represents the interests of small businesses in Massachusetts, have experienced a years-long struggle “where they face a double-digit increase in their health insurance premiums. So we’re constantly searching for solutions and looking at ways to lower their costs.”

    A single-payer system is one way to do that, said Cote-L’Heureux.

    “In 2026 the state is likely to spend about $126 billion on health care. If single-payer were implemented in 2026, we could eliminate $55 billion of unnecessary spending.” 

    According to Mass-Care’s analysis, implementing statewide Medicare for All would eliminate $54.5 billion in state spending on administrative costs and physician, hospital, and drug prices. A total of $24.7 billion of that savings would go to “expanding coverage and correcting underpayment of Medicaid services,” while the rest would be filtered back into the economy.

    Most Bay Staters would financially benefit too; under the measure, every Massachusetts resident earning under $500,000 per year would save money. According to Mass-Care, over 98% of Massachusetts households would spend less on health care than they do now.

    “As a proportion of their income, low-income people pay much more in premiums, deductibles and co-pays than high-income people, and the impact of this is identical to the impact of a regressive tax,” said Cote-L’Heureux. “And by switching to single-payer, we would effectively adjust that regressive tax, which currently goes by the name of premiums, deductibles and co-pays, to become a fair tax.”  

    “Single-payer would, by default, increase equality of access to health care in Massachusetts,” he said. 

    This is not the first time that a state has attempted to implement a universal health care plan. In 2011, the Vermont Legislature implemented Green Mountain Care, the first state-level single-payer health care system in the United States. Despite initial optimism, the plan was abandoned in 2014 due to the state’s inability to find funding for it.

    “Vermont got the closest look at it, but never did implement it,” said Rennie. “It’s not an idea that’s going away, but I just don’t think any state could do it on their own.”

    Proponents of the Massachusetts bill say that the state won’t run into the same problems that Vermont did. According to Cote-L’Heureux, “one of the big strengths of the current bill in Massachusetts is that there’s a clear revenue plan.”

    The bill would create the Massachusetts Health Care Trust to administer single-payer health insurance, and collect and manage the system’s finances. Universal health care in Massachusetts would require $46 billion in funding; to attain it, the bill would implement five payroll taxes, each with a $20,000 exemption.

    The bill would establish a 7.5% tax on small employers, an 8% tax on large employers (businesses with more than 100 employees), a 2.5% income tax on employees, a 10% income tax on self-employed people, and a 10% tax on non-payroll income. 

    Rennie suggested a tax increase portends doom for the state economy.

    “The system in the bill would be funded by a system of new payroll taxes on employees and the self-employed. So kind of dedicated payroll taxes to replace what we’re spending on insurance premiums and out-of-pocket spending,” said Rennie. 

    “We think that would have a very devastating, kind of killing, effect on the economy, and it would be something that would incentivize businesses and employees to bleed the state.”

    He also cited the role of health care providers in the cost equation.

    “Cost is still the primary concern that we really need to try and get a hold of,” said Rennie. “And from our point of view, a lot of it’s on market control of certain providers.” 

    It was a sentiment shared by Lora Pellegrini, CEO of the Massachusetts Association of Health Plans, which represents insurers, in a statement to the State House News Service following a public hearing on the bill last year.

    “Mandating a one-size-fits-all, government-run health care system would eliminate meaningful health care choices for patients and require dramatic tax increases on residents and employers across the Commonwealth,” Pellegrini said. 

    “It would also jeopardize the significant progress Massachusetts has made in achieving near-universal coverage and divert attention from the urgent work needed to control the actual drivers of rising health care costs, namely, unchecked provider prices and the skyrocketing cost of prescription drugs.”

    To others, a tax increase would simply save people money.

    “For a lot of people that’s a scary idea, that they’re going to see their taxes go up in order to pay for health care for everybody,” said Cote-L’Heureux. “If we compare the taxes that individuals will pay under single-payer to the amount that individuals are paying right now for health care through premiums, deductibles and co-pays, there is no comparison. Individuals will be paying much less through taxation than they currently do.”

    Sabadosa pointed out efforts by Group Insurance Commission, which manages health care coverage for state employees to rein in costs.

    “We’re seeing members of the GIC working really hard to try to keep the cost-sharing down for those plans, to keep full coverage that they’ve had, as plans are trying to shed different treatments in order to save money.”

    Cote-L’Heureux was blunter.

    “We’ve seen health care prices increase much faster than the rate of inflation over the last 20, 25 years. If health care costs were only increasing because it costs more for hospitals and physicians to treat patients, the increase in health care costs should be much closer to the level of inflation,” he said. “We’ve seen huge increases in profits by insurance companies and, especially in Massachusetts, monopoly profits among insurance companies and hospitals.”

    Sabadosa said that ultimately, “Change scares people, but at the same time, change is very necessary.”

  • Educators air views on Right to Read bill

    BOSTON — A panel of state educators, legislators, and a national education expert shared perspectives and answered questions raised by parents and teachers about the Right to Read Act at a State House roundtable last week.

    The discussion, hosted by Educators for Excellence, included Boston Public School principal Antonelli Mejia, state Sen. Sal DiDomenico (D-Everett), and Heather Peske, president of the National Council on Teacher Quality. The bill, which seeks to reform early literacy instruction, advanced in the House in October and in the Senate in January.

    Addressing critics of the bill who are opposed to a state-mandated list of approved curricula, Mejia said that time is the “most critical resource” that impedes local autonomy. He argued that developing curricula takes valuable time, which could otherwise be spent analyzing teaching methods and educating children.

    “If there were a list of already vetted materials that are considered high-quality, that are research based, then we can focus our energy on what really matters,” said Mejia, “which is, how do we compact the curriculum, and how can we be critical consumers of the material before we put it in front of our babies?’”

    Peske said that state-mandated curricula are “not a one size fits all approach. There’s a robust list. Districts will always have a choice of curriculum that they want to use. We just want to ensure that the choices are the best choices and that they don’t contain a bunch of defunct methods.”

    The panel also addressed opposition to the bill from the Massachusetts Teachers Union. The union in January stated that it is concerned that “any mandated curriculum will inevitably leave behind some students who are struggling with reading.” The union also wrote that the waiver process, which grants education licenses, “is not structured to support proven results but instead is focused on bending school districts toward compliance with theoretical approaches.”

    “I historically have been on their (the union’s) side on many, many issues,” said Sen. DiDomenico. “But this is where we took a sharp break. I told them, ‘I’m not pro MTA, I’m pro kids.’ And that’s where the divide was put down.”

    “It was telling and disappointing, quite frankly, to hear some detractors who were at the higher level of the union saying one thing, representing teachers, when most of the teachers were saying, ‘we need something different.’”

    Educators stressed that a change was necessary as over 60% of fourth-graders in Massachusetts are reading at a below-third grade level.

    “The status quo isn’t working for over half the children in our state that are in third grade,” DiDomenico said. “If we don’t address it in a meaningful way through legislation, then we are failing our kids.”

    “We don’t have time to wait. Our kids don’t have time. They’re in third grade, they’re in second grade, they’re in first grade only for a finite amount of time. And if we let them go beyond those grade levels and not get what they need, then we’re just making them get into a cycle of more pain and suffering.”

    DiDomenico is part of the conference committee that will draft a final version of the bill, approved by the House and the Senate.

    “I will make sure we pack all the good things that we put in our bill and add some good things the House did as well,” he said. “We are going to start that process in the next couple of weeks, and then we should have a bill to the governor’s desk shortly after.”

    James Noyes writes for the Gazette from the Boston University Statehouse Program.